small molecule

MIEBO

PERFLUOROHEXYLOCTANE

Loss of exclusivityJune 2037latest FDA-listed patent expiry

CompanyBAUSCH AND LOMB INC

Drug detail

Brand name	MIEBO
Active ingredient	PERFLUOROHEXYLOCTANE
Strength	1.338GM/ML
Dosage form	SOLUTION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	May 2023
Marketing status	RX

Listed patents

Patent	Expires	Type
10507132	June 2037	use U-1900
11357738	September 2036	product
10576154	October 2035	use U-1900
10449164	September 2033	use U-1900
10369117	September 2033	use U-1900
10058615	September 2033	use U-1900

Regulatory exclusivity

Code	Expires
NCE	May 2028

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from BAUSCH AND LOMB INC